MUSTANG BIO, INC. — Director's Dealing 2017

Jun 30, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2016-09-26

Reporting Person: Herskowitz Neil (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (Restricted)	50000	Direct
Common Stock (Restricted)	10000	Direct

Footnotes

F1: The 50,000 shares are restricted common stock, which will vest and become non-forfeitable according to the following schedule: 16,667 shares on 6/8/2020, 16,667 shares on 6/8/2021 and 16,666 shares on 6/8/2022, subject to the Mr. Herskowitz's continued service on the Board on such date.

F2: The 10,000 shares are restricted common stock, which will vest on 6/8/2020, subject to Mr. Herskowitz's continued service on the board on such date.